Sol-Gel Technologies (SLGL) EBITDA Margin Growth (1y) (2019 - 2026)
Sol-Gel Technologies (SLGL) EBITDA Margin Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Sol-Gel Technologies | 227.58 Mn | 217.44 Mn | - | 268,981.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 268,981.00 |
| Dec 31, 2025 | 170,380.00 |
| Sep 30, 2025 | -155,656.00 |
| Jun 30, 2025 | 3,517.00 |
| Dec 31, 2024 | -98,427.00 |
| Sep 30, 2024 | 294,559.00 |
| Jun 30, 2024 | 112,871.00 |
| Dec 31, 2023 | 499,538.00 |
| Sep 30, 2023 | -157,214.00 |
| Jun 30, 2023 | -111,198.00 |
| Dec 31, 2022 | -627,208.00 |
| Sep 30, 2022 | -148,410.00 |
| Jun 30, 2022 | -85,343.00 |
| Mar 31, 2022 | -60,237.00 |
| Dec 31, 2021 | 39,207.00 |
| Sep 30, 2021 | 50,962.00 |
| Jun 30, 2021 | 20,013.00 |
| Mar 31, 2021 | 39,403.00 |
| Dec 31, 2020 | 79,511.00 |
| Sep 30, 2020 | -57,634.00 |